Company Monitoring Page for Daiichi-Sankyo

latest headlines for company on cafepharma

Indian merger creates fifth-largest generic drugmaker
Medical Marketing and Media
Mon, 12/8/14 - 11:23 pm
Tags:
India, M&A, generics, Sun Pharma, Ranbaxy, Daiichi Sankyo
FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Fri, 10/31/14 - 02:01 pm
Tags:
FDA, Daiichi Sankyo, advisory panels, bloodthinners, Savaysa, edoxaban
FDA staff recommends limited use of Daiichi's blood thinner
Yahoo/Reuters
Tue, 10/28/14 - 11:34 am
Tags:
Daiichi Sankyo, FDA, bloodthinners, edoxaban, atrial fibrillation
Is Ambit Biosciences Getting Enough in Its Buyout?
Yahoo/24-7 Wall St
Mon, 09/29/14 - 01:53 pm
Tags:
M&A, Ambit Biosciences, Daiichi Sankyo
Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Bloomberg
Mon, 09/29/14 - 07:55 am
Tags:
Daiichi Sankyo, Ambit Biosciences, M&A
Daiichi Sankyo bets up to $650M on Charleston's pain potential
Fierce Biotech
Thu, 08/7/14 - 09:51 am
Tags:
Daiichi Sankyo, Charleston Laboratories, painkillers, CL-108, hydrocodone
10 big brands keep pumping out big bucks, with a little help from price hikes
Fierce Pharma Marketing
Wed, 05/7/14 - 03:42 pm
Tags:
Xyrem, Jazz Pharmaceuticals, Humulin, Eli Lilly, Premarin, Mylan, Lunesta, Sunovion, Benicar, Daiichi Sankyo, Lantus, Sanofi, Viagra, Pfizer, Gleevec, Novartis, Copaxone, Teva Pharmaceuticals, EpiPen, drug pricing
Daiichi Sankyo pledges bold action on Ranbaxy production problems
Reuters
Fri, 01/31/14 - 08:16 am
Tags:
drug manufacturing, Daiichi Sankyo, Ranbaxy
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes
Thu, 12/5/13 - 06:45 pm
Tags:
bloodthinners, Pradaxa, Boehringer Ingelheim, Xarelto, JNJ, Eliquis, Pfizer, Bristol-Myers Squibb, edoxaban, Daiichi Sankyo
Pfizer And GlaxoSmithKline: Aiming For Melanoma Cure Supremacy
Seeking Alpha
Thu, 12/5/13 - 06:43 pm
Tags:
Pfizer, GSK, melanoma, Bristol-Myers Squibb, AstraZeneca, Daiichi Sankyo, Novartis, Yervoy, palbociclib, Mekinist, Zelboraf
New Anticoagulant From Daiichi Sankyo Works Well In AF Patients
Forbes
Tue, 11/19/13 - 12:35 pm
Tags:
Daiichi Sankyo, edoxaban, bloodthinners, Warfarin, atrial fibrillation
Can The First Malaria Vaccine Drive GlaxoSmithKline's Growth?
Seeking Alpha
Wed, 10/16/13 - 08:35 am
Tags:
GSK, vaccines, malaria, Agenus, Daiichi Sankyo, RTS,S, JNJ
Data on ArQule's Tivantinib
Yahoo/Zacks
Sat, 10/5/13 - 09:18 am
Tags:
Arqule, tivantinib, Daiichi Sankyo, lung cancer, non-small cell lung cancer
ArQule up on hope for lung cancer drug revival
Reuters
Fri, 09/27/13 - 11:51 am
Tags:
Arqule, tivantinib, Daiichi Sankyo, lung cancer
Daiichi Sankyo’s New Blood Thinner Matched Warfarin in Study
Bloomberg
Tue, 09/3/13 - 09:27 am
Tags:
bloodthinners, Daiichi Sankyo, Warfarin, edoxaban
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Mon, 05/13/13 - 12:27 pm
Tags:
Astellas, Xtandi, Daiichi Sankyo, Japan, Takeda, prostate cancer
Encouraging Phase 1 data with lead compound, ARQ 092, to be presented at AACR
Yahoo
Mon, 04/1/13 - 10:58 am
Tags:
ARQ092, Daiichi Sankyo, Arqule, akt protein inhibitor, cancer
Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
Seeking Alpha
Tue, 01/15/13 - 11:39 am
Tags:
tivantinib, Arqule, colorectal cancer, Daiichi Sankyo
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thu, 12/13/12 - 04:29 pm
Tags:
Arqule, Daiichi Sankyo, ARQ-087
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tue, 10/2/12 - 11:25 am
Tags:
Arqule, lung cancer, Daiichi Sankyo, tivantinib, non-small cell lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.